dc.contributor.author | Sohrabi, N | |
dc.contributor.author | Farajnia, S | |
dc.contributor.author | Akhi, MT | |
dc.contributor.author | Nahaei, MR | |
dc.contributor.author | Naghili, B | |
dc.contributor.author | Peymani, A | |
dc.contributor.author | Amiri, Z | |
dc.contributor.author | Rezaee, MA | |
dc.contributor.author | Saeedi, N | |
dc.date.accessioned | 2018-08-26T09:32:37Z | |
dc.date.available | 2018-08-26T09:32:37Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57385 | |
dc.description.abstract | Carbapenems have been considered as last line antibiotics for treatment of multidrug-resistant (MDR) Acinetobacter baumannii but carbapenem resistant A. baumannii has been increased during the last decade in many parts of the world. OXA-type ?-lactamase enzymes are the most common cause of carbapenem resistance in A. baumannii and presence of ISAba1 in upstream of these genes may increase the expression of these OXA genes. The aim of this study was to determine, for the first time, the antibiotic resistance pattern and prevalence of OXA type ?-lactamases among nosocomial A. baumannii isolates from northwest of Iran. A total of 100 A. baumannii isolates were recovered from hospitalized patients in a university hospital in northwest of Iran. Sixty-two percent of isolates were resistant to imipenem. All isolates carried bla OXA-51-like gene. Among imipenem resistant isolates, 88.7% carried blaOXA-23-like, 1.6% carried blaOXA-40-like, and 3.2% had blaOXA-58-like resistance genes. Ninety percent of isolates contained ISAba1 element and in 74.2% of imipenem resistant isolates, ISAba1 was located in upstream of blaOXA-23-like. The results of this study demonstrated high prevalence of OXA-type carbapenemase among MDR A. bumanii in the Northwest of Iran. é 2012 Mary Ann Liebert, Inc. | |
dc.language.iso | English | |
dc.relation.ispartof | Microbial Drug Resistance | |
dc.subject | amikacin | |
dc.subject | ampicillin | |
dc.subject | antibiotic agent | |
dc.subject | bacterial DNA | |
dc.subject | beta lactam antibiotic | |
dc.subject | beta lactamase | |
dc.subject | carbapenem | |
dc.subject | cefepime | |
dc.subject | ceftazidime | |
dc.subject | ceftriaxone | |
dc.subject | ciprofloxacin | |
dc.subject | clavulanic acid | |
dc.subject | colistin | |
dc.subject | cotrimoxazole | |
dc.subject | gentamicin | |
dc.subject | imipenem | |
dc.subject | levofloxacin | |
dc.subject | meropenem | |
dc.subject | piperacillin | |
dc.subject | piperacillin plus tazobactam | |
dc.subject | polymyxin B | |
dc.subject | sulbactam | |
dc.subject | ticarcillin | |
dc.subject | Acinetobacter baumannii | |
dc.subject | antibiotic resistance | |
dc.subject | article | |
dc.subject | bacterial growth | |
dc.subject | bacterium culture | |
dc.subject | bacterium isolate | |
dc.subject | controlled study | |
dc.subject | Gram negative bacterium | |
dc.subject | growth inhibition | |
dc.subject | hospital infection | |
dc.subject | hospital patient | |
dc.subject | human | |
dc.subject | Iran | |
dc.subject | nonhuman | |
dc.subject | polymerase chain reaction | |
dc.subject | prevalence | |
dc.subject | priority journal | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Acinetobacter baumannii | |
dc.subject | Acinetobacter Infections | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Bacterial Typing Techniques | |
dc.subject | beta-Lactam Resistance | |
dc.subject | beta-Lactamases | |
dc.subject | Carbapenems | |
dc.subject | DNA Transposable Elements | |
dc.subject | Female | |
dc.subject | Genes, Bacterial | |
dc.subject | Humans | |
dc.subject | Iran | |
dc.subject | Male | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Middle Aged | |
dc.subject | Plasmids | |
dc.subject | Polymerase Chain Reaction | |
dc.subject | Acinetobacter baumannii | |
dc.title | Prevalence of oxa-type ?-lactamases among Acinetobacter baumannii isolates from northwest of Iran | |
dc.type | Article | |
dc.citation.volume | 18 | |
dc.citation.issue | 4 | |
dc.citation.spage | 385 | |
dc.citation.epage | 389 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1089/mdr.2011.0077 | |